Targeted SERCA2a Gene Expression Identifies Molecular Mechanism and Therapeutic Target for Arrhythmogenic Cardiac Alternans
Michael J. Cutler(Mount Sinai Hospital), David Rosenbaum(MetroHealth Medical Center), Roger J. Hajjar(Boston Biomedical Research Institute), Kenneth R. Laurita(MetroHealth), Xiaoping Wan(Shanghai First People's Hospital)
Cited by 128
Related Papers
Electrical Alternans and Vulnerability to Ventricular Arrhythmias
|New England Journal of Medicine|1994|1.1k
Multi-ethnic genome-wide association study for atrial fibrillation
|Nature Genetics|2018|824
Mechanism Linking T-Wave Alternans to the Genesis of Cardiac Fibrillation
|Circulation|1999|820
Sudden Cardiac Death Prediction and Prevention
|Circulation|2010|608